300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Blockchain
Facebook
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Web3
Medical
Theatre
Recruiting
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Nigeria
Isle of Man
Pakistan
Zambia
Romania
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Colombia
Oman
Cameroon
India
Australia
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Germany
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United Kingdom
United States
Canada
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Ireland
Peru
Slovenia
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors (June 2026)

The most active venture capital funds investing in Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
SOSV
VC Fund
87 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Innova Memphis
VC Fund
58 United States, Argentina, United Kingdom Seed, Pre-Seed Health Care, Medical, Medical Device $25k–$1.7M
Bpifrance
VC Fund
56 France, United States, Switzerland Seed, Series A Software, Information Technology, Health Care $694k–$35M
OrbiMed
VC Fund
54 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$150M
Qiming Venture Partners
VC Fund
51 China, United States, Hong Kong Series B, Series A, Series C Health Care, Biotechnology, Medical $5M–$142M
ARCH Venture Partners
VC Fund
49 United States, China, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7.8M–$250M
New Enterprise Associates
VC Fund
46 United States, India, United Kingdom Series A, Series B, Series C Software, Health Care, Biotechnology $5.3M–$103M
BioVenture
VC Fund
42 China, United States, Hong Kong Series A, Series B, Seed Health Care, Medical, Biotechnology $1.6M–$73M
Alumni Ventures
VC Fund
41 United States, United Kingdom, Canada Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.4M–$79M
F-Prime
VC Fund
39 United States, United Kingdom, China Series A, Series B, Series C Health Care, Biotechnology, Medical $9.2M–$130M
General Catalyst
VC Fund
38 United States, United Kingdom, India Series A, Seed, Series B Software, Artificial Intelligence, Health Care $1.6M–$135M
Polaris Partners
VC Fund
38 United States, Ireland, Singapore Series B, Series A, Series C Biotechnology, Health Care, Medical $4.5M–$107M
Novo Holdings
VC Fund
36 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9M–$130M
Connecticut Innovations
VC Fund
35 United States, Israel, Canada Seed, Series A Health Care, Biotechnology, Software $200k–$25M
HSG
VC Fund
35 China, United States, Hong Kong Series A, Series B, Series C Health Care, Biotechnology, Software $4.4M–$214M
Gaingels
VC Fund
34 United States, Canada, Mexico Seed, Series A, Series B Software, Health Care, Artificial Intelligence $1.4M–$100M
Sofinnova Partners
VC Fund
33 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6M–$120M
Khosla Ventures
VC Fund
33 United States, India, United Kingdom Series A, Series B, Seed Software, Artificial Intelligence, Health Care $2M–$100M
Atlas Venture
VC Fund
32 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.2M–$115M
Versant Ventures
VC Fund
32 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $4.7M–$108M
Google Ventures
VC Fund
30 United States, United Kingdom, Israel Series A, Series B, Seed Software, Health Care, Biotechnology $1M–$107M
Alexandria Venture Investments
VC Fund
30 United States, Canada, France Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$150M
Right Side Capital Management
VC Fund
29 United States, Canada, United Kingdom Seed, Pre-Seed, Convertible Note Software, SaaS, Health Care $18k–$2M
Enterprise Ireland
VC Fund
29 Ireland, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $494k–$12M
Wavemaker 360
VC Fund
29 United States, United Kingdom, Canada Seed, Series A Health Care, Medical, Medical Device $700k–$16M
KdT Ventures
VC Fund
29 United States, India, Canada Seed, Series A, Series B Biotechnology, Health Care, Medical $2.6M–$175M
Canaan Partners
VC Fund
29 United States, United Kingdom, Israel Series A, Series B, Series C Software, Biotechnology, Health Care $5M–$75M
Med-Fine Capital
VC Fund
29 China, Hong Kong, United States Series A, Seed, Series B Medical, Health Care, Biotechnology $2.8M–$60M
StartUp Health
VC Fund
29 United States, Canada, United Kingdom Seed, Pre-Seed Health Care, Wellness, Medical $20k–$4M
Third Rock Ventures
VC Fund
28 United States Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $11M–$150M
HTGF (High-Tech Gruenderfonds)
VC Fund
28 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $909k–$40M
Lux Capital
VC Fund
28 United States, United Kingdom, Canada Series A, Seed, Series B Software, Artificial Intelligence, Health Care $1.8M–$150M
Andreessen Horowitz
VC Fund
27 United States, United Kingdom, Brazil Series A, Seed, Series B Software, Information Technology, Artificial Intelligence $1.5M–$107M
Forbion Capital Partners
VC Fund
26 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical $15M–$176M
Cowin Venture
VC Fund
26 China, United States, Hong Kong Series A, Angel, Series B Health Care, Medical, Biotechnology $425k–$257M
Lilly Asia Ventures
VC Fund
26 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $14M–$259M
Wisconsin Investment Partners
VC Fund
26 United States, Canada, United Kingdom Seed, Series A Health Care, Biotechnology, Medical $400k–$7M
Legend Capital
VC Fund
26 China, United States, South Korea Series B, Series A, Series C Health Care, Medical, Biotechnology $2.8M–$200M
RA Capital Management
VC Fund
26 United States, United Kingdom, Canada Series B, Series C, Post-IPO Equity Biotechnology, Health Care, Therapeutics $26M–$235M
Parkwalk Advisors
VC Fund
25 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $982k–$46M
8VC
VC Fund
25 United States, United Kingdom, Canada Series A, Seed, Series B Software, Health Care, Artificial Intelligence $2.7M–$175M
Prox Ventures
VC Fund
25 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $1.9M–$28M
Rock Health Capital
VC Fund
25 United States, Denmark Seed, Series A, Series B Health Care, Software, Medical $20k–$63M
Sanofi Ventures
VC Fund
25 United States, United Kingdom, France Series B, Series A, Series C Biotechnology, Health Care, Medical $9M–$150M
Sante Ventures
VC Fund
25 United States, Canada, Japan Series A, Series B, Series C Health Care, Medical, Biotechnology $1.9M–$80M
TEDCO
VC Fund
24 United States, Canada, United Kingdom Seed, Grant, Pre-Seed Health Care, Software, Biotechnology $25k–$2.5M
Omega Funds
VC Fund
24 United States, Switzerland, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $14M–$208M
Shanghai Biomedical Industrial Equity Investment Fund
VC Fund
24 China, United States, Hong Kong Series A, Seed, Series B Health Care, Medical, Biotechnology $8M–$142M
Green Park & Golf Ventures
VC Fund
24 United States, Israel, Sweden Series A, Seed, Series B Health Care, Medical, Biotechnology $420k–$45M
BioAdvance
VC Fund
24 United States, Canada Seed, Series A Biotechnology, Health Care, Medical $200k–$40M
Access all 13440 VC funds in Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

SOSV
VC Fund · Princeton, New Jersey, United States · 87 investments in Medical startups, 70 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Innova Memphis
VC Fund · Memphis, Tennessee, United States · 58 investments in Medical startups

Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Pre-Seed
  • Geography: United States, Argentina, United Kingdom

Investor stats

  • Total investments: 251
  • Round size: Seed $50k–$1.7M; Pre-Seed $25k–$1.3M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • HerdDogg — HerdDogg is passionate about livestock. Its innovative data platform sits at the intersection of agtech, the internet of things, and global food security. Our patented DoggTags and DoggBone, together with our Animal Traceability Platform, help producers make more money from every animal they raise. The HerdDogg system enables animal tracking,welfare monitoring and traceability in an easy-to-use application. For more information, visit herddogg.com.
  • Insignum AgTech — Insignum AgTech develops biotech plants that communicate with producers, alerting them to an illness in its early stages.
  • Rescue Forensics — Customer service is our #1 priority. Get a premium domain for your website today. Financing available.
Show all investments...

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 56 investments in Medical startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 1069
  • Round size: Seed $694k–$6.9M; Series A $2.6M–$35M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Verkor — Verkor is a battery cell manufacturer whose goal is to increase the production of low-carbon batteries to fulfill the growing demand for electric vehicles. The company focuses on the development of low-carbon batteries with a carbon footprint that is many times smaller than standard batteries. This reduces the logistics footprint, includingemissions, and provides businesses with batteries that are very inexpensive and use carbon-free electricity.
  • WAAT — WAAT operates fast charging stations for electric and rechargeable hybrid vehicles. Its services are aimed at all private sector market segments, including condominiums, lessees, tertiary, and real estate development. The company was founded in 2018 and is based in Paris with sales offices in Malakoff and Bagneux (92).
  • BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 54 investments in Medical startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 588
  • Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$143M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Galecto — Damora Therapeutics is working to fundamentally redefine care for people with blood disorders by bringing forward optimized therapies that dramatically improve patient outcomes.
  • Insilico Medicine — Artificial Intelligence for Drug Discovery and Aging Research
  • Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Show all investments...

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 51 investments in Medical startups

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 739
  • Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $887M in 2023

Portfolio highlights

  • Duet — Duet is a dating application helps you find meaningful relationships based on shared interests and experiences.
  • SPEEDIANCE — Speediance specializes on smart self-serviced gym equipment. The company develops smart fitness equipment and an online platform to provide training guidance and courses about strength training, enabling individual users to connect with the workout community and have better home workout experiences.
  • moodytiger — Technology-Driven & Design-Led Activewear for Kids moodytiger aims to create revolutionary activewear that is comfortable, multi-functional, and stylish for children aged from 4 to 14 years old.
Show all investments...

ARCH Venture Partners
VC Fund · Chicago, Illinois, United States · 49 investments in Medical startups

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 387
  • Round size: Series A $7.8M–$212M; Series B $13M–$250M; Series C $15M–$175M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Ultivue — Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that helps to understand of biology and medicine. Ultivue's products are designed for fluorescent microscopy-based research and willeventually be valuable for clinical diagnostic use. It was founded in 2015 and headquartered in Cambridge, Massachusetts.
  • EGenesis — At eGenesis, we envision a world where transplantation is accessible to all. We develop safe and effective human-compatible organs for transplantation.
  • Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
Show all investments...

New Enterprise Associates
VC Fund · Menlo Park, California, United States · 46 investments in Medical startups

Foundational partners to ambitious founders at every stage of company-building.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1539
  • Round size: Series A $5.3M–$60M; Series B $10M–$80M; Series C $13M–$103M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $2.8B in 2022

Portfolio highlights

  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
  • Allay Therapeutics — SUPPORTING PATIENTS THROUGH EVERY PHASE OF RECUPERATION The first technology designed to deliver weeks of localized pain management
  • Regulus Therapeutics — Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteinsbut instead regulate gene expression. It was founded in 2007 and is headquartered in Carlsbad, California.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 42 investments in Medical startups

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 163
  • Round size: Seed $1.6M–$20M; Series A $1.9M–$43M; Series B $3M–$73M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Human Zhizao — Human Intelligent Manufacturing is a fully automatic multiple flow fluorescence platform.
  • DiaMonTech AG — DiaMonTech is developing a medical device for non-invasive measurement of blood sugar values. The patented process uses laser technology to determine and control blood glucose values of diabetes patients without any pain and without drawing blood.
  • MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Show all investments...

Alumni Ventures
VC Fund · Manchester, New Hampshire, United States · 41 investments in Medical startups

Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 1426
  • Round size: Seed $1.4M–$10M; Series A $5.2M–$37M; Series B $12M–$79M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Classiq Technologies — A software platform that helps users create scalable complex quantum computer algorithms, software, and circuits for any gate-based quantum computer
  • Eclypsium — Eclypsium's platform enhances supply chain security by incorporating zero-trust in every device, fortifying hardware, firmware, and software.
  • Veda — Veda is the largest vault infrastructure platform in DeFi, enabling institutions to launch and manage onchain financial products at scale.
Show all investments...

F-Prime
VC Fund · Cambridge, Massachusetts, United States · 39 investments in Medical startups

F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, China

Investor stats

  • Total investments: 422
  • Round size: Series A $9.2M–$87M; Series B $16M–$130M; Series C $22M–$115M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • 1upHealth — 1upHealth is the trusted interoperability solutions provider for health plans looking to acquire, manage, exchange, analyze, and use clinical data and claims data.
  • Simon Data — Simon Data empowers CRM teams with the data, tools, & support to drive personalization at every customer touchpoint.
  • CHARM Therapeutics — CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
General Catalyst
VC Fund · Cambridge, Massachusetts, United States · 38 investments in Medical startups

Investing in powerful, positive change that endures

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 1589
  • Round size: Seed $1.6M–$18M; Series A $6M–$70M; Series B $12M–$135M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Pylon — Talk to your customers over Slack, Microsoft Teams, or Discord? Meet Pylon. We'll help you scale your sales, success, and support processes over chat and integrate that data back into your existing systems.
  • ClearSky Data — ClearSky Data’s global storage network simplifies the entire data lifecycle and delivers enterprise storage as a fully managed service.Its storage is designed for business agility. ClearSky simplifies enterprise storage by providing an SLA-based managed service across the global network. The company's patent-pending Smart Tiered Cachingcontinually categorizes data and places it in the right cache layer (hot, warm, cold) based on evolving usage requirements and customer policies. Customers simply scale as needed, using the ClearSky dashboard to add unlimited capacity with a few clicks. All data can be moved across the ClearSky network to meet a variety of use cases including data center migration, load balancing, expansion into new regions, or disaster recovery. ClearSky has partnered with major public clouds to place hot and warm cache copies at the cloud edge. The result: customers get low-latency access to cloud instances, providing a new cost-effective option to run their most demanding workloads.The total cost of ownership (TCO) of storing data using the ClearSky service is about 1/3 the cost of managing it in a company’s data center on physical storage arrays.By leveraging the architecture and building redundancy into all cache layers and network paths, ClearSky is able to provide an enterprise-class service with guaranteed high availability. Industry-leading security technologies and best practices ensure that customer data is always protected and isolated from the moment it enters the ClearSky network. Customers simply plug into the ClearSky service to get the storage they need, when and where they need it, with the security, scalability, and resilience that a business depends on.
  • Ping Identity — Ping Identity provides cloud-based identity management software for companies and government organizations. They help enterprises achieve Zero Trust identity-defined security & more personalized, streamlined user experiences. The Ping Intelligent Identity Platform provides customers, employees, partners, and, increasingly, IoT, with access tothe cloud, mobile, SaaS, and on-premises applications and APIs, while also managing identity and profile data at scale. Ping Identity was founded in 2002 and headquartered in Denver, Colorado.
Show all investments...

Polaris Partners
VC Fund · Boston, Massachusetts, United States · 38 investments in Medical startups

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Ireland, Singapore

Investor stats

  • Total investments: 450
  • Round size: Series A $4.5M–$80M; Series B $7M–$107M; Series C $10M–$100M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $182M in 1998

Portfolio highlights

  • Thirty Madison — Thirty Madison is a human-first healthcare company, powering access to affordable specialized healthcare through brands like Keeps and Cove.
  • CliQr Technologies — CliQr is a leading provider of application-defined cloud management solutions. Offering full lifecycle management delivered in a single, intuitive packaged platform, CliQr enables businesses to easily and efficiently model, deploy and manage one to many applications, users, and clouds.CliQr’s application-defined technology de-couplesapplications from the complexity of hybrid cloud environments, allowing them to securely move, deploy and manage new and existing application across any physical, virtual or cloud environment.CliQr’s patented and patent-pending technology and its global partners help dozens of leading brands in healthcare, manufacturing and technology markets manage their cloud application lifecycles in over 15 different data center, private and public cloud environments.Headquartered in San Jose, California, with locations in Canada, India and Czech Republic, CliQr is backed by Polaris Partners, Foundation Capital, Google Ventures and TransLink Capital. For additional information, visit www.cliqr.com.
  • Invivyd — Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patientsand clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with thirdparty contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 36 investments in Medical startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 334
  • Round size: Series A $9M–$120M; Series B $12M–$130M; Series C $30M–$118M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • AlloCure — AlloCure is a biotechnology company, develops cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries. It offers biological therapeutics for acute kidney injuries. AlloCure is based in Burlington, Massachusetts. It has operations in Salt Lake City, Utah, and Hamburg, Germany.The company isdedicated to the development of off-the-shelf biological therapies to treat serious and debilitating diseases that afflict millions of people around the world. AlloCure's unique technology uses processed cells derived from human bone marrow to treat a wide variety of diseases. AlloCure was founded on the unique and proprietary technology developed by Dr. Christof Westenfelder and Dr. Axel Zander. Westenfelder and Zander are world-renowned scientists who have dedicated their careers to developing effective therapies for kidney disease. AlloCure has operations in Salt Lake City Utah and Hamburg Germany.
  • PTC Therapeutics — Translating Science. Transforming Lives.
  • Breye Therapeutics — Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases.
Show all investments...

Connecticut Innovations
VC Fund · Rocky Hill, Connecticut, United States · 35 investments in Medical startups

At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 250
  • Round size: Seed $200k–$5.3M; Series A $2.4M–$25M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $50M in 2023

Portfolio highlights

  • Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
  • Ruckus Media Group — At Ruckus Media, they are reinventing family entertainment—and taking it on the road—with original apps for iPad, iPhone, Droid, and other mobile media platforms. They bring Jon Scieszka, Rosemary Wells, Andrew Clements, Patricia MacLachlan, Alan Katz, David Carter, Kevin Lewis, Mike Austin, and Caitlin Friedman, among many other bestsellingauthors and illustrators, animators, celebrity performers and musicians together with talented editors and software developers to create a completely new form of storytelling.When children open Ruckus apps, turning and tilting pages, touching words and art, they read, see, and enter a story. Words, pictures, music, and dynamics made possible only by touch screen technology are woven to tell original stories to entrance and expand their imaginations. As with their favorite picture books, children will be enriched by and return to Ruckus apps again and again.
  • Axerion Therapeutics — Axerion Therapeutics, Inc. is a private Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury.Axerion was established in New Haven to develop and commercialize intellectual propertylicensed from Dr. Stephen Strittmatter’s laboratory at Yale University. Axerion’s proprietary technology platforms include blockers of ß-amyloid (Aß) oligomers binding to Prion Proteins (PrP) on the cell surface of neurons as a novel therapeutic target for Alzheimer’s disease and Nogo Receptor decoy protein for recovery of neurological function in spinal cord injury and other neurological diseases.
Show all investments...

HSG
VC Fund · Beijing, Beijing, China · 35 investments in Medical startups, 10 in the past 12 months

We help founders build enduring companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 751
  • Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
  • Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
  • Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Show all investments...

Gaingels
VC Fund · New York, New York, United States · 34 investments in Medical startups

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 754
  • Round size: Seed $1.4M–$8M; Series A $6M–$40M; Series B $16M–$100M
  • Lead/follow: 1% lead, 99% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Quadient Accounts Receivable by YayPay — YayPay accounts receivable automation software helps businesses collect faster, forecast cash flow accurately, and improve payment process. Automate your AR
  • Sharper Sense — Neuromodulation for Clear Senses
  • Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 33 investments in Medical startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 308
  • Round size: Series A $6M–$67M; Series B $10M–$120M; Series C $12M–$100M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • EndoRon Medical — Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.
  • BrightHeart — BrightHeart develops an AI-based platform for fetal ultrasound analysis to improve detection of congenital heart defects.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

Khosla Ventures
VC Fund · Menlo Park, California, United States · 33 investments in Medical startups

Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1084
  • Round size: Seed $2M–$17M; Series A $5.5M–$44M; Series B $10M–$100M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $557M in 2022

Portfolio highlights

  • Caelux — Solar: Amplified Caelux is a pioneer in utilizing perovskites to make solar energy more powerful and cost-effective, enabling the next generation of solar innovation. PV 3.0 is Here. As competing technologies battle it out to improve solar return on
  • Even — Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.
  • Loop — Loop Health is bringing ease and choice to patients seeking major medical treatments. We've brought together family physicians, top specialists, and leading hospitals in Pune – to provide options, transparency, and ease to patients and their families. Loop Coordinators help patients match with a doctor, compare treatment costs, get secondopinions, and complete admission formalities – removing the stress and making lives easier for the patient and their families.
Show all investments...

Atlas Venture
VC Fund · Cambridge, Massachusetts, United States · 32 investments in Medical startups

Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 418
  • Round size: Series A $3.2M–$75M; Series B $8M–$115M; Series C $6M–$95M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Judo Bio — Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new treatments for systemic and renal diseases.
  • Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
  • Remix Therapeutics — Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
Show all investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 32 investments in Medical startups

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 282
  • Round size: Series A $4.7M–$80M; Series B $10M–$105M; Series C $12M–$108M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Stablix — Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.
  • Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
  • Lycia Therapeutics — Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Google Ventures
VC Fund · Mountain View, California, United States · 30 investments in Medical startups

GV supports innovative founders moving the world forward.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 1029
  • Round size: Seed $1M–$15M; Series A $5.4M–$88M; Series B $15M–$107M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2014

Portfolio highlights

  • Smarterer — Individuals and Fortune 500 companies use Smarterer to help close the gap between the skills they have and the skills they need. Their dynamic assessment engine leverages the freshest crowdsourced tests around, to rapidly pinpoint skill level with a credible score. In November 2014, Pluralsight, the global leader in online learning for serioussoftware developers, IT specialists and creative technologists, acquired Smarterer. As the world's largest curated e-learning library for professionals, the company offers instant access to more than 3,500 courses authored by top experts. Smarterer will continue to power crowdsourced assessments for freelancer marketplaces, e-learning providers and enterprise companies anywhere people need to prove their skills to connect with professional opportunities. The Smarterer community has answered over 56 million during 1.7 million test sessions, across hundreds of tests.
  • Zest — Give your shoppers the swiftest gifting experience in ecommerce. With Zest, shoppers on your site can send a gift to anybody, anywhere with just a link.
  • EpiBiologics — EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.
Show all investments...

Alexandria Venture Investments
VC Fund · Pasadena, California, United States · 30 investments in Medical startups

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 246
  • Round size: Seed $2M–$31M; Series A $12M–$100M; Series B $25M–$150M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • miRecule — MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics. It features a genomic-based drug development platform that integrates genomic sequencing, expression, and prognostic data from cancer patients. The company was founded in 2016 and headquartered in Gaithersburg, United States.
  • Marvin Health — Marvin is a mental health service for physicians. We're ending the one-size-fits-all approach to teletherapy, helping you to set a teletherapy action plan.
  • Deep Genomics — Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.
Show all investments...

Right Side Capital Management
VC Fund · San Francisco, California, United States · 29 investments in Medical startups

Systematic Pre-Seed Startup Capital

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 720
  • Round size: Seed $18k–$2M; Pre-Seed $50k–$450k; Convertible Note $50k–$500k
  • Lead/follow: 4% lead, 96% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Etho — Etho is an all in one augmented reality voice command assistant for motorcycle riders. Etho's first product, is a platform for existing helmet manufacturers to build smart helmets with a voice assistant for motorcycle riders, that exist within an augmented reality heads up display.Etho's mission is to improve the relationship betweenrider and machine by giving them an entire solution. By partnering with the best motorcycle helmet manufactures in the industry, they are able to focus their efforts on building the best technology for riders. They enable the riders to win by offering them the safest helmets, powered by a technology that delivers a distraction-free riding experience.
  • Hutsy — Hutsy Financial is a financial services company that provides mobile banking, early payroll access and credit building products. In partnership with Peoples Trust we provide a prepaid debit card that our users can spend with. We also offer cash back on all purchases, spending insights, and categorizations to provide valuable insight on where yourmoney is going. Hutsy was recently on CBC’s Dragons Den where we raised our pre-seed funding round of $500,000 to bring our product to life.
  • Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Show all investments...

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 29 investments in Medical startups

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 506
  • Round size: Seed $494k–$3.3M; Series A $2.2M–$12M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $1.1M in 2021

Portfolio highlights

  • Tirlan — Tirlan is an agricultural company that supplies agri-food and farm input materials to the framing sector.
  • Pulsate — Pulsate enables direct communication with customers based on their location, context, interests and behaviours. Pulsate allows you to design and push rich media content directly to customers devices. Deepen the relationship by establishing a customer dialogue. Allow users to reply to your campaigns, provide feedback and keep complaints outside ofsocial media. Maximize foot traffic by targeting street level or competitor locations. Combine with segmentation for optimal results. iBeacons:tm: enable you to understand indoor customer location and context with incredible accuracy. Easily manage deployment and configuration of iBeacons:tm: with the Pulsate cloud platform. Gain a deeper understanding of your mobile customers and a comprehensive view of each mobile campaign.
  • Lakeland Dairies — Lakeland Dairies, a major dairy processing co-operative, operates within a fifteen county catchment area across the northern half of the island of Ireland. The Group processes about one billion litres of quality milk annually into a range of value added dairy foodservice products and functional dairy food ingredients.
Show all investments...

Wavemaker 360
VC Fund · Pasadena, California, United States · 29 investments in Medical startups

Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 77
  • Round size: Seed $700k–$6M; Series A $1.9M–$16M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: Likely still investing — raised $64M in 2022

Portfolio highlights

  • FreeNav, Inc. — FreeNav is simplifying and standardizing the position tracking of procedural instrumentation for medical applications and procedures.
  • Hermes Health — Big IdeaHermes Health is a secure, neutral middleware platform that simplifies and standardizes access to identified patient health data. We connect Requestors (e.g., attorneys, CROs, analytics firms) with Partners (e.g., ROI vendors, EHR providers, RWD sources) who hold and manage this data.ProblemAccessing identified health data remainslargely manual and outdated—relying on phone calls, faxes, and mailed records. This process is fragmented, costly, and inefficient. Requestors face a maze of disconnected workflows, while Partners are bogged down by inconsistent standards and manual tasks.SolutionHermes Health offers a scalable API and the Unity Platform to power secure, patient-consented data workflows. We reduce integration complexity and contractual friction by enabling seamless connectivity between Requestors and our network of Partners.The Unity Platform integrates with Partners as they are—plugging into existing APIs or co-developing new ones to match their systems. Whether you're a requestor or a data custodian, Hermes Health accelerates access while preserving security and compliance.
  • Esperto Medical — Esperto Medical is an Irvine, CA-based medical device company developing next-generation wearable diagnostics that enable hospital-based and remote patient monitoring with unprecedented ease and accuracy. Its unique resonance sonomanometry technology uses acoustic stimulation to directly and noninvasively measure continuous blood pressure withoutcalibration.
Show all investments...

KdT Ventures
VC Fund · Austin, Texas, United States · 29 investments in Medical startups

KdT Ventures is the standard for early-stage frontier science investing.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 89
  • Round size: Seed $2.6M–$13M; Series A $8.5M–$70M; Series B $25M–$175M
  • Lead/follow: 9% lead, 91% follow
  • Last fund: Likely still investing — raised $80M in 2022

Portfolio highlights

  • Elegen — Skip cloning with the only entirely cell-free DNA synthesis provider. Sequences up to 7 kb. Error rates as low as 1:70,000/bp. Manufactured in USA, NGS-verified and shipped globally in as few business days.
  • Checkerspot — A biology-driven platform creating specialized lipids from fermentation
  • Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Show all investments...

Canaan Partners
VC Fund · Menlo Park, California, United States · 29 investments in Medical startups

Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 655
  • Round size: Series A $5M–$40M; Series B $7.8M–$75M; Series C $7.1M–$55M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $100M in 2024

Portfolio highlights

  • Hermeus — Hermeus is developing hypersonic aircraft to connect the world faster than ever before.
  • WorkMotion — WorkMotion offers Global HR Solutions to help companies navigate the New Ways of Working. Solutions fully compliant.
  • Savvy — Savvy is a software development company that engages in cybersecurity.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 29 investments in Medical startups

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 78
  • Round size: Seed $8M–$60M; Series A $2.8M–$40M; Series B $11M–$60M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $69M in 2019

Portfolio highlights

  • Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
  • Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
  • BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Show all investments...

StartUp Health
VC Fund · New York, New York, United States · 29 investments in Medical startups

Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots

Show more...

Investment focus

  • Industry: Health Care, Wellness, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 194
  • Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
  • Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
  • NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Show all investments...

Third Rock Ventures
VC Fund · Boston, Massachusetts, United States · 28 investments in Medical startups

Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace. Third Rock Ventures believes in the companies we start and makes significant initial investments, which are frequently supplemented by strategic collaborations, to help our firmsprogress in life-changing medicines, technologies, and diagnostics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States

Investor stats

  • Total investments: 148
  • Round size: Series A $17M–$110M; Series B $11M–$150M; Series C $14M–$146M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • CytomX Therapeutics — CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.
  • Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
  • Synnovation Therapeutics — Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, andpatient-focused precision medicine, it builds a diverse pipeline of novel small-molecule targeted therapies. It aims to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 28 investments in Medical startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 555
  • Round size: Seed $909k–$7.4M; Series A $3M–$40M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $522M in 2022

Portfolio highlights

  • TRAIT — TRAIT Running Coach app for your iphone or ipad tablet.
  • Certivity — Certivity offers software to model digital regulatory twins of their products. This will ensure that current regulatory requirements are integrated in the right place in the engineering process. Product compliance will be smarter, safer, more transparent, more efficient, and significantly cheaper.
  • Scavenger AI — Scavenger AI helps businesses transform complex data into clear, actionable insights.
Show all investments...

Lux Capital
VC Fund · New York, New York, United States · 28 investments in Medical startups

Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 520
  • Round size: Seed $1.8M–$30M; Series A $7M–$60M; Series B $13M–$150M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2007

Portfolio highlights

  • Plexium — Plexium harnesses a differentiated platform of proprietary technologies and approaches to establish a robust and diverse portfolio.
  • Clarifai — Clarifai is the leading Machine Learning, Computer Vision, NLP Platform. Label, train, deploy models on one AI platform for developers & data scientists.
  • Primer — Primer makes powerful mission-ready AI software designed to work in your environment, on your data. We help national security teams sift through massive unstructured data sets to find the needle in the haystack, understand and visualize their data, and act collaboratively. Our mission is to empower decisions that can be defended, and acted upon confidently.
Show all investments...

Andreessen Horowitz
VC Fund · Menlo Park, California, United States · 27 investments in Medical startups

Andreessen Horowitz (a16z) is a venture capital firm in Silicon Valley, California, investing in bold founders, innovators, and entrepreneurs building the future through technology.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Brazil

Investor stats

  • Total investments: 1628
  • Round size: Seed $1.5M–$15M; Series A $9M–$53M; Series B $16M–$107M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Shapeways — Shapeways is the #1 online 3D printing service company. Working with over a million customers since 2007 - Get 3D products and parts delivered to over 100 countries.
  • Dapper Labs — Dapper Labs uses the power of play to deliver blockchain-based experiences that are made for you and ready for the real world.
  • Genesis Molecular AI — Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction.The company was founded in 2019and based in South San Francisco, California.
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 26 investments in Medical startups

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 187
  • Round size: Series A $16M–$176M; Series B $15M–$155M; Series C $19M–$113M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
  • Noema Pharma — DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Cowin Venture
VC Fund · Beijing, Beijing, China · 26 investments in Medical startups

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Angel, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 97
  • Round size: Angel $425k–$1.4M; Series A $1.4M–$28M; Series B $2.8M–$257M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Furong Biotech — Furong Bio is a developer of innovative tumor immunology drugs.
  • Amador Bioscience — At Amador we provide global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
  • BioTroy Therapeutics — BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 26 investments in Medical startups

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 211
  • Round size: Series A $14M–$100M; Series B $25M–$112M; Series C $28M–$259M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
  • Ronovo Surgical — Founded in 2019 and headquartered in Shanghai, Ronovo Surgical is founded by industry veterans from global leaders in surgical and industrial robotics, such as Intuitive Surgical, Johnson & Johnson, Medtronic and KUKA. Aiming to transform how surgery is performed in China, Ronovo is leveraging robust R&D capabilities and strategicpartnerships globally to accelerate the development of a broad portfolio of MIS and digital surgery solutions that exemplifies the core themes of simplicity, precision, and intelligence.
  • Tmunity Therapeutics — Tmunity Therapeutics is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), universal engineered T cell platforms, and Chimeric Antigen....
Show all investments...

Wisconsin Investment Partners
VC Fund · Madison, Wisconsin, United States · 26 investments in Medical startups

Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members. Membership has grown to 50+ members in recent years, bringing significant knowledge and experience.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 115
  • Round size: Seed $400k–$3M; Series A $1.1M–$7M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • DropCap — DropCap is a tech-enabled rights agency (dropcap.com) and a global rights marketplace used by rights agents and acquisitions editors around the world to find great books (dropcapmarketplace.com). Our mission is to provide independent authors and publishers access to rights licensing opportunities and help indie books go global through foreignrights, audio, and film rights licensing.
  • Cylerity — Transform healthcare receivables into real-time capital. Cylerity unlocks cash flow, clarity, and control from claims data. See how it works.
  • Midwest Games — Midwest Games is a video game publisher focused on creating opportunities for the abundant talent across the Midwest and other underrepresented regions.
Show all investments...

Legend Capital
VC Fund · Beijing, Beijing, China · 26 investments in Medical startups

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 386
  • Round size: Series A $2.8M–$94M; Series B $12M–$113M; Series C $14M–$200M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $177M in 2021

Portfolio highlights

  • Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
  • ESWIN Computing — ESWIN Computing provides research and development of RISC-V computing architecture.
  • Yosemite Clinic — Yosemite Clinic is a full-service clinic providing convenient walk-in medical services in a state-of-the-art environment in Central Pudong. They offer family medicine, internal medicine, surgery, orthopedics (sports medicine), dermatology, medical cosmetology, dentistry, gynecology, pediatrics, ophthalmology, anesthesiology, rehabilitationmedicine, medical imaging, laboratory, pharmacy and more. Their onsite facilities and equipment include CT, X-ray, Ultrasound, Laboratory and Operating Rooms. Their doctors come from China and across the world, enabling us to serve you in many languages including, English, Japanese, Malay, Mandarin Chinese and Cantonese.
Show all investments...

RA Capital Management
VC Fund · Boston, Massachusetts, United States · 26 investments in Medical startups

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Post-IPO Equity
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 447
  • Round size: Series B $26M–$152M; Series C $40M–$200M; Post-IPO Equity $34M–$235M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
  • Terrestrial Bio — Vaxess engineers novel technologies that uniquely engage the human immune system, enabling improved efficacy and simplified access for vaccines and therapeutics.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 25 investments in Medical startups

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 259
  • Round size: Seed $982k–$5M; Series A $1.6M–$13M; Series B $2M–$46M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PhoreMost — PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savingsonto patients.
  • Bramble Energy — Bramble Energy is an innovator energy technology company that designs and manufactures high-performance, low-cost, and fuel cell stack. The company ability to leverage the global high-volume PCB industry means that they are the first fuel cell company with the manufacturing capacity to supply gigawatts of fuel cell hardware, something the batteryindustry has spent many years and £B’s to achieve.Bramble Energy specifically uses a printed circuit board (PCB) technology to form the structural parts of the fuel cell. It also provides products including modular PCBFC stacks, H20:20W PCBFC system, custom design PCBFC, and 500W PCBFC stack.Bramble Energy was founded in 2016 and is based in London, England, United Kingdom.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
8VC
VC Fund · San Francisco, California, United States · 25 investments in Medical startups

8VC is a technology and life sciences investment firm that partners with founders to develop transformational technologies. The firm focuses on creating long-term economic and societal value through its investments across various sectors, including healthcare and logistics.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 479
  • Round size: Seed $2.7M–$13M; Series A $7.4M–$55M; Series B $16M–$175M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • Nest Health — Nest Health is a primary care company that offers whole person, whole family care for families from birth through age five in urban areas. Nest offers primary and pediatric care for families, made affordable and convenient.
  • Hello Patient — Healthcare AI that gets your team off the phone & in front of patients
  • Better Health — Better Health is a Modern Medical Supplier focused on delivering Urology & Ostomy Supplies. Shop the latest Catheters, Ostomy Bags from Hollister, Convatec, Coloplast and many more.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 25 investments in Medical startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 76
  • Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • DotBio — DotBio is a biopharmaceutical company specialized in next-generation domain antibody therapies.
  • Coastar Therapeutics — Coastar Therapeutics develops an erythrocyte enveloped virus delivery technology platform to perform repeated virus dosing. It evades recognition and attack by the immune system to address the challenges of systemic and repeated administration of drug therapies. Coastar's process technology and “red blood cell membranes only” enable thecompany to overcome the challenges of mass production and standardization, and has cost advantages. The company's first product targets oncolytic viruses and is developing ELCV solutions for other therapies.The company was founded in 2017 and is based in San Diego, CAlifornia.
  • Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.
Show all investments...

Rock Health Capital
VC Fund · San Francisco, California, United States · 25 investments in Medical startups, 6 in the past 12 months

Rock Health Capital is a full-service seed fund that invests in and supports startups working in digital health. The company invests in entrepreneurs working at the intersection of healthcare and technology. Rock Health Capital is a digital health-focused investment firm.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, Denmark

Investor stats

  • Total investments: 115
  • Round size: Seed $20k–$4.2M; Series A $4.7M–$34M; Series B $8M–$63M
  • Lead/follow: 6% lead, 94% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Burst — Burst | FSA & HSA Checkout, Reimbursements, and LMNs anywhere
  • No Barrier
  • Rosarium Health — Rosarium Health is a platform that connects service providers (home contractors and occupational therapists) with customers to execute accessible house assessments and accessible home modifications at a client's primary home, leased property, or company.
Show all investments...

Sanofi Ventures
VC Fund · Cambridge, Massachusetts, United States · 25 investments in Medical startups

Sanofi Ventures invests in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 113
  • Round size: Series A $9M–$81M; Series B $30M–$150M; Series C $30M–$120M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $750M in 2001

Portfolio highlights

  • AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
  • Lava Therapeutics — Innovation in engaging gamma-delta T cells to potently and precisely fight cancer
  • OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
Show all investments...

Sante Ventures
VC Fund · Austin, Texas, United States · 25 investments in Medical startups

Privately Held Companies

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: United States, Canada, Japan

Investor stats

  • Total investments: 114
  • Round size: Series A $1.9M–$32M; Series B $2.6M–$61M; Series C $5M–$80M
  • Lead/follow: 61% lead, 39% follow
  • Last fund: Likely still investing — raised $260M in 2021

Portfolio highlights

  • Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
  • SONIRE Therapeutics — SONIRE Therapeutics is a clinical-stage medical device company. It is a U.S. subsidiary of SONIRE Therapeutics Co., Ltd..
  • Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
Show all investments...

TEDCO
VC Fund · Columbia, Maryland, United States · 24 investments in Medical startups

TEDCO is an independent organization that strives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Grant, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 250
  • Round size: Seed $100k–$2.5M; Grant $25k–$1M; Pre-Seed $25k–$900k
  • Lead/follow: 65% lead, 35% follow

Portfolio highlights

  • Truvelop — Truvelop is an agile and adaptive workforce performance evaluation tool to motivate and retain employees, and improve the health of your organization
  • Foretrace — Foretrace provides Continuous Automated Reconnaissance using the same exact tools, techniques, and OSINT as real cyber adversaries. This provides our customers visibility into the attackers view of their digital footprint, as well as that of their subsidiaries, vendors, partners, and/or customers.
  • Omni Biosciences — Omni Biosciences is a minority women-owned biotechnology company.
Show all investments...

Omega Funds
VC Fund · Boston, Massachusetts, United States · 24 investments in Medical startups

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 149
  • Round size: Series A $16M–$197M; Series B $35M–$162M; Series C $14M–$208M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Ousia Pharma — Ousia Pharma is paving the way for novel therapeutic strategies using peptide-drug-conjugates
  • Andrew Alliance — OneLab is laboratory software to design and execute liquid handling protocols. Pipette+ for manual liquid handling pipetting and Andrew+ the pipetting robot
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Show all investments...

Shanghai Biomedical Industrial Equity Investment Fund
VC Fund · Huangpu, Shanghai, China · 24 investments in Medical startups

Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 63
  • Round size: Seed $8M–$50M; Series A $10M–$36M; Series B $14M–$142M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
  • SiBionics — SiBionics is a medtech specialized in R&D & commercialization of implantable medical devices and medical imaging artificial intelligence.
  • Hexaell Biotech — Hexaell Biotechnology Co., Ltd is a start-up company pioneering in stem cell and artificial organ. The disruptive technologies were original published in "Nature. 475(7356):386-9" and "Cell Stem Cell. 14(3):370-84" from Chinese Academy of Sciences. Hexaell Biotechnology had licensed iHep and HiHep technologies from ChineseAcademy of Sciences and developed medical devices of bio-artificial liver to replace liver function of human and cure liver failure diseases. Hexaell has finished pilot clinical studies in 6 liver failure patients in leading hepatopathy centers in China.
Show all investments...

Green Park & Golf Ventures
VC Fund · Dallas, Texas, United States · 24 investments in Medical startups

Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: United States, Israel, Sweden

Investor stats

  • Total investments: 93
  • Round size: Seed $420k–$3.2M; Series A $1.3M–$18M; Series B $2.1M–$45M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Vellum Health — Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients.
  • Affineon Health — Affineon is the AI inbox that saves provider time. We automatically handle normal and clinically insignificant lab results, and help providers get through abnormal lab results faster. Our AI automatically groups, analyzes, and trends lab results into a smart summary, including possible next steps and a complete patient note. We also route"noise" to staff, reducing the number of messages a physician needs to pay attention to by up to 30%. The result is 5+ hours saved per week per provider. Plus, Affineon tightly integrates with the EHR, so providers don’t need to change their existing workflow.
  • Mobia Medical — MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.
Show all investments...

BioAdvance
VC Fund · Philadelphia, Pennsylvania, United States · 24 investments in Medical startups

BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United States, Canada

Investor stats

  • Total investments: 118
  • Round size: Seed $200k–$2.5M; Series A $3M–$40M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: May invest from a new fund soon — raised $20M in 2002

Portfolio highlights

  • Latus Bio — Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.
  • Tolerance Bio — Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance. Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergi
  • Vittoria Biotherapeutics — Vittoria Biotherapeutics develops gene-edited cell therapies.  they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.
Show all investments...

Medical VC funding at a glance

Stats across 20k deals from 13k investors.

13k
investors
in Medical startups
20k
deals
in Medical startups
$6.8M
median round
in Medical startups
45%
lead investors
lead at least one round
20%
Seed
most common funding stage

Access all 13440 VC funds in Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 13440 VC funds investing in Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists